Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis
Clinical trial NCT06582329 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06582329
- Sponsor
- Medical University Innsbruck
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2025-07-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.